Next Generation News and Research

RSS

EdgeBio introduces Science as a Service concept built on top of CLC Genomics Server

Today at the inaugural Beyond Sequencing conference in San Francisco, EdgeBio introduced their Science as a Service concept built on top of CLC bio's enterprise platform, CLC Genomics Server. EdgeBio's end-to-end service concept leads each scientist and project from conception and project design through bioinformatics and analysis.

23 Jun 2010

Benioff family gifts $100 million for construction of new UCSF Children's Hospital at Mission Bay

Salesforce.com chairman and CEO Marc Benioff and his family have given a $100 million private gift to help fund the construction of the new UCSF Children's Hospital at the UCSF Mission Bay campus near downtown San Francisco. The gift is both the largest gift the donors have ever made and the largest gift ever granted specifically to the UCSF Children's Hospital.

22 Jun 2010

First anniversary of Family Smoking Prevention and Tobacco Control Act

One year ago, President Obama signed the historic Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act). Under the Tobacco Control Act, the U.S. Food and Drug Administration obtained authority to regulate tobacco products, with a special emphasis on preventing their use by children and youth and reducing the impact of tobacco on public health.

22 Jun 2010

FDA to hold workshop on medical device innovation to address unmet public health needs

Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.

22 Jun 2010

Millar, Telemetry Research partner to offer TRM53P implantable transmitters

Millar Instruments, Inc., a medical device manufacturing firm and developer of pressure sensing technology, has released the TRM53P implantable transmitter through the partnership with Telemetry Research, Ltd. The TRM53P is the world's first, fully implantable transmitter that combines Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.

21 Jun 2010

Exiqon licenses LNA technology to BD for diagnosing infectious diseases

Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.

From BD (Becton, Dickinson and Company) 21 Jun 2010

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule.

21 Jun 2010

Research may identify reasons underlying increased risk of AAA in men

Research currently being undertaken at the University of Leicester may identify reasons underlying an increased risk of Abdominal Aortic Aneurysms in men.

19 Jun 2010

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Life Technologies Corporation, a provider of innovative life science solutions, today announced activities and product launches in concert with the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting that highlight the company's offerings of complete end-to-end solutions for stem cell research. Stem cell research has been shown to be a critical component of regenerative medicine; a basis for identifying drug targets and drug screening; and an important step in the development of therapies to treat a variety of diseases.

18 Jun 2010

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced that it has received preliminary results for CLOSURE I, its patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in the U.S.

18 Jun 2010

HRA Pharma announces FDA Advisory Committee approval for ulipristal acetate as emergency contraceptive

HRA Pharma announced today that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive.

18 Jun 2010

AMP raises ethical, laboratory practice concerns in whole genome sequencing at SACHGS meeting

Today, the Association for Molecular Pathology (AMP) presented public comments to the Secretary's Advisory Committee on Genetics, Health and Society (SACHGS) meeting focused on whole genome sequencing. In anticipation of advances in sequencing and its incorporation into clinical practice, AMP raised ethical and laboratory practice concerns for the Committee's consideration.

17 Jun 2010

Research studies may lead to future development of cell transplant therapy for ALS

The University of California, San Diego, The Salk Institute for Biological Studies and Life Technologies Corporation today announced the initiation of studies which may lead to the future development of cell transplant therapy for amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. Currently, there is only one FDA-approved pharmaceutical addressing this lethal disease, which affects approximately 30,000 people in the United States.

17 Jun 2010

HHS Secretary announces series of new investments to strengthen primary care workforce

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced a series of new investments worth $250 million to increase the number of health care providers and strengthen the primary care workforce. The new investments were made possible by the Affordable Care Act. Sebelius was joined for the announcement by U.S. Representative Lois Capps, Health Resources and Services Administration Administrator Dr. Mary Wakefield, and HHS Assistant Secretary for Health Dr. Howard K. Koh.

17 Jun 2010

Opinions: Maintain fight against HIV/AIDS; Ending PMTCT; Impact of U.S. health reform on foreign-trained physicians

Following a recent trip to the largest HIV/AIDS clinic in Uganda, U.N. Secretary-General Ban Ki-Moon reflects on the recent progress made in the fight against the disease in a McClatchy opinion piece. Though "Uganda was the epicenter of the AIDS epidemic. …Uganda is also a success story," Ban writes. "A decade ago, fewer than 10,000 people were on the new generation of antiretroviral drugs that suppress the disease and offer the promise of a normal life.

17 Jun 2010

Curis reports topline results from GDC-0449 Phase II clinical trial for metastatic colorectal cancer

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced topline results from a Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class Hedgehog pathway inhibitor. GDC-0449 was tested in combination with Avastin® (bevacizumab) and FOLFOX or FOLFIRI chemotherapy in first-line metastatic colorectal cancer patients.

17 Jun 2010

Scientists receive over $3M to launch training and mentorship programs for promising young researchers

Scientists from the Universit- de Montr-al and its affiliated engineering school, -cole Polytechnique, have received major funding from the National Sciences and Engineering Research Council of Canada. Over $3 million was awarded to enable both institutions to launch training and mentorship programs for promising young researchers.

17 Jun 2010

IRX Therapeutics raises $8M to further develop pipeline of cancer vaccine candidates

IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead product, IRX-2. IRX Therapeutics has now raised a total of more than $80 million in private financing.

17 Jun 2010

AGA Medical commences enrollment in AMPLATZER Cardiac Plug clinical trial

AGA Medical Holdings, Inc. today announced first patient enrollment in the feasibility phase of the prospective, multicenter, randomized AMPLATZER® Cardiac Plug clinical trial. Dr. William Nicholson, an interventional cardiologist and structural heart specialist at York Hospital in Pennsylvania, enrolled the first patient.

16 Jun 2010

Health Care IT market set for continued growth over next five years: Compass Intelligence

New research from Compass Intelligence shows that the Health Care IT market is primed for continued growth over the next five years. Compass Intelligence expects health care organizations including hospitals, doctors' offices, private practices, clinics and other health care organizations to spend an estimated $73.1 Billion this year on IT products, services and solutions.

16 Jun 2010

Next Generation News and Research

EdgeBio introduces Science as a Service concept built on top of CLC Genomics Server

Benioff family gifts $100 million for construction of new UCSF Children's Hospital at Mission Bay

First anniversary of Family Smoking Prevention and Tobacco Control Act

FDA to hold workshop on medical device innovation to address unmet public health needs

Millar, Telemetry Research partner to offer TRM53P implantable transmitters

Exiqon licenses LNA technology to BD for diagnosing infectious diseases

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Research may identify reasons underlying increased risk of AAA in men

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

HRA Pharma announces FDA Advisory Committee approval for ulipristal acetate as emergency contraceptive

AMP raises ethical, laboratory practice concerns in whole genome sequencing at SACHGS meeting

Research studies may lead to future development of cell transplant therapy for ALS

HHS Secretary announces series of new investments to strengthen primary care workforce

Opinions: Maintain fight against HIV/AIDS; Ending PMTCT; Impact of U.S. health reform on foreign-trained physicians

Curis reports topline results from GDC-0449 Phase II clinical trial for metastatic colorectal cancer

Scientists receive over $3M to launch training and mentorship programs for promising young researchers

IRX Therapeutics raises $8M to further develop pipeline of cancer vaccine candidates

AGA Medical commences enrollment in AMPLATZER Cardiac Plug clinical trial

Health Care IT market set for continued growth over next five years: Compass Intelligence

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News